title: Loss of spastic paraplegia gene atlastin induces age-dependent death of dopaminergic neurons in Drosophila.
abstract: Hereditary spastic paraplegias (HSPs) are human genetic disorders causing increased stiffness and overactive muscle reflexes in the lower extremities. atlastin (atl) is one of the major genes in which mutations result in HSP. We generated a Drosophila model of HSP that has a null mutation in atl. As they aged, atl null flies were paralyzed by mechanical shock such as bumping or vortexing. Furthermore, the flies showed age-dependent degeneration of dopaminergic neurons. These phenotypes were rescued by targeted expression of atl in dopaminergic neurons or feeding L-DOPA or SK&F 38393, an agonist of dopamine receptor. Our data raised the possibility that one of the causes of HSP disease symptoms in human patients with alt mutations is malfunction or degeneration of dopaminergic neurons.
authors.affiliation: Department of Biological Sciences, Korea Advanced Institute of Science & Technology, 373-1 Guseong-Dong, Yuseong-Gu, Daejeon 305-701, Republic of Korea.
authors.forename: Youngseok
authors.initials: Y
authors.lastname: Lee
authors.forename: Donggi
authors.initials: D
authors.lastname: Paik
authors.forename: Sunhoe
authors.initials: S
authors.lastname: Bang
authors.forename: Jongkyun
authors.initials: J
authors.lastname: Kang
authors.forename: Bumkoo
authors.initials: B
authors.lastname: Chun
authors.forename: Seungbok
authors.initials: S
authors.lastname: Lee
authors.forename: Eunkyung
authors.initials: E
authors.lastname: Bae
authors.forename: Jongkyung
authors.initials: J
authors.lastname: Chung
authors.forename: Jaeseob
authors.initials: J
authors.lastname: Kim
mesh_terms: D015647:2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine / Q000008:administration & dosage; D000375:Aging; D000818:Animals; D030801:Animals, Genetically Modified; D016923:Cell Death / Q000235:genetics; D049109:Cell Proliferation; D004298:Dopamine / Q000378:metabolism*; D018491:Dopamine Agonists / Q000008:administration & dosage; D004330:Drosophila; D029721:Drosophila Proteins / Q000235:genetics / Q000378:metabolism; D004625:Embryo, Nonmammalian / Q000502:physiology; D020558:GTP Phosphohydrolases / Q000172:deficiency*; D019204:GTP-Binding Proteins; D005786:Gene Expression Regulation / Q000187:drug effects / Q000235:genetics*; D049452:Green Fluorescent Proteins / Q000235:genetics; D007980:Levodopa / Q000008:administration & dosage; D008297:Male; D008565:Membrane Proteins; D009474:Neurons / Q000187:drug effects / Q000473:pathology*; D016415:Sequence Alignment / Q000379:methods; D014446:Tyrosine 3-Monooxygenase / Q000235:genetics
chemical_list: D018491:Dopamine Agonists; D029721:Drosophila Proteins; D008565:Membrane Proteins; D049452:Green Fluorescent Proteins; D007980:Levodopa; D015647:2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; D014446:Tyrosine 3-Monooxygenase; C440006:ATL1 protein, human; D020558:GTP Phosphohydrolases; D019204:GTP-Binding Proteins; D004298:Dopamine